DK3737713T3 - Carrageenan-Based Compositions for Films and Capsules - Google Patents

Carrageenan-Based Compositions for Films and Capsules Download PDF

Info

Publication number
DK3737713T3
DK3737713T3 DK18829234.6T DK18829234T DK3737713T3 DK 3737713 T3 DK3737713 T3 DK 3737713T3 DK 18829234 T DK18829234 T DK 18829234T DK 3737713 T3 DK3737713 T3 DK 3737713T3
Authority
DK
Denmark
Prior art keywords
carrageenan
capsules
films
based compositions
compositions
Prior art date
Application number
DK18829234.6T
Other languages
English (en)
Other versions
DK3737713T1 (da
Inventor
Thomas Worm
Jens Eskil Trudsø
Original Assignee
Cp Kelco Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=67140593&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3737713(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cp Kelco Aps filed Critical Cp Kelco Aps
Publication of DK3737713T1 publication Critical patent/DK3737713T1/da
Application granted granted Critical
Publication of DK3737713T3 publication Critical patent/DK3737713T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08L3/02Starch; Degradation products thereof, e.g. dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18Manufacture of films or sheets
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/0008Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/0016Plasticisers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/05Alcohols; Metal alcoholates
    • C08K5/053Polyhydroxylic alcohols
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2303/00Characterised by the use of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08J2303/02Starch; Degradation products thereof, e.g. dextrin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2403/00Characterised by the use of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08J2403/02Starch; Degradation products thereof, e.g. dextrin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2405/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Grain Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK18829234.6T 2018-01-10 2018-12-10 Carrageenan-Based Compositions for Films and Capsules DK3737713T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862615460P 2018-01-10 2018-01-10
US16/170,120 US10711119B2 (en) 2018-01-10 2018-10-25 Carrageenan-based compositions for films and capsules
PCT/EP2018/084233 WO2019137717A1 (en) 2018-01-10 2018-12-10 Carrageenan-based compositions for films and capsules

Publications (2)

Publication Number Publication Date
DK3737713T1 DK3737713T1 (da) 2020-11-30
DK3737713T3 true DK3737713T3 (en) 2022-10-17

Family

ID=67140593

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18829234.6T DK3737713T3 (en) 2018-01-10 2018-12-10 Carrageenan-Based Compositions for Films and Capsules

Country Status (14)

Country Link
US (1) US10711119B2 (da)
EP (1) EP3737713B1 (da)
JP (1) JP7097449B2 (da)
KR (1) KR102354921B1 (da)
CN (1) CN111566158B (da)
AU (1) AU2018401537B2 (da)
DE (1) DE18829234T1 (da)
DK (1) DK3737713T3 (da)
ES (1) ES2796329T3 (da)
HU (1) HUE059850T2 (da)
PH (1) PH12020551041A1 (da)
PL (1) PL3737713T3 (da)
PT (1) PT3737713T (da)
WO (1) WO2019137717A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114306272A (zh) * 2019-06-12 2022-04-12 江苏艾兰得营养品有限公司 一种植物软胶囊及其制备方法与用途
EP4243786A1 (en) * 2020-11-11 2023-09-20 R.P. Scherer Technologies, LLC Delayed release softgel capsules
WO2023072546A1 (en) * 2021-10-25 2023-05-04 Unilever Ip Holdings B.V. Films and capsules

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089307A (en) * 1989-05-23 1992-02-18 Mitsubishi Rayon Co., Ltd. Edible film and method of making same
GB9705770D0 (en) 1997-03-20 1997-05-07 Scherer Corp R P Gelatin encapsulation techniques
FR2767070B1 (fr) * 1997-08-08 1999-09-17 Laurence Paris Composition visqueuses aqueuses, limpides ou non, pour la fabrication de capsules molles et de capsules dures, et procede de fabrication de films pour de telles capsules
US6063915A (en) 1998-07-30 2000-05-16 Hercules Incorporated Carrageenan compositions and methods for their production
ES2226418T5 (es) * 1998-09-30 2009-01-01 Warner-Lambert Company Llc Composiciones para recubrimiento de almidon modificado.
US6340473B1 (en) 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
EP1598062A1 (en) 1999-07-07 2005-11-23 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
NO20021592D0 (no) * 2002-04-04 2002-04-04 Fmc Biopolymer As Polysakkaridkapsler og fremgangsmåte ved fremstilling derav
BRPI0409329A (pt) 2003-04-14 2006-04-25 Fmc Corp processo para fabricar pelìculas de gel termorreversìveis, homogêneas, pelìcula homogênea, termorreversìvel, de sólidos altos, umidade baixa, processo para fabricar cápsulas moles, cápsulas moles, processo para fabricar uma forma de dosagem sólida, forma sólida, processo para preparar uma sistema de liberação de pelìcula de gel homogênea, e, sistema de liberação
US20050013847A1 (en) * 2003-04-14 2005-01-20 Fmc Corporation Delivery systems of homogeneous, thermoreversible alginate films
US7816341B2 (en) 2003-04-14 2010-10-19 Fmc Corporation Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom
CN1871016A (zh) * 2003-04-14 2006-11-29 Fmc有限公司 含κ-2角叉胶的均质热可逆凝胶膜输送系统
US20050008677A1 (en) * 2003-04-14 2005-01-13 Fmc Corporation Delivery system of homogeneous, thermoreversible gel film containing kappa-2 carrageenan
US8231896B2 (en) 2004-11-08 2012-07-31 R.P. Scherer Technologies, Llc Non-gelatin soft capsule system
JP5021263B2 (ja) 2006-10-02 2012-09-05 中日本カプセル 株式会社 皮膜用組成物
US8574624B2 (en) * 2006-11-17 2013-11-05 Corn Products Development, Inc. Highly inhibited starch fillers for films and capsules
US20080317789A1 (en) 2007-06-25 2008-12-25 Cp Kelco U.S., Inc. Carrageenan Process
CN101229450A (zh) 2007-11-01 2008-07-30 南京普生医药科技开发有限公司 一种干燥软胶囊的方法
US8293285B2 (en) 2008-03-14 2012-10-23 Cp Kelco U.S., Inc. Carrageenan modified by ion-exchange process
KR101038696B1 (ko) 2009-06-19 2011-06-02 후지 캡슐 가부시키가이샤 소프트 캡슐 및 그 제조 방법
CN102470095A (zh) 2009-08-07 2012-05-23 Fmc有限公司 牙膏组合物
US8900628B2 (en) 2010-02-26 2014-12-02 Nisshin Kasei Co., Ltd. Hard capsule and method for producing same
AU2010358565B2 (en) * 2010-08-04 2016-07-14 R.P. Scherer Technologies, Llc Film-forming composition for soft capsules
KR101401193B1 (ko) 2010-11-22 2014-05-28 후지 캡슐 가부시키가이샤 연질 캡슐 피막
JP5769760B2 (ja) 2013-06-25 2015-08-26 アール.ピー. シェーラー テクノロジーズ エルエルシー ソフトカプセル用シェル形成組成物及びソフトカプセル
WO2016047825A1 (ko) 2014-09-25 2016-03-31 코스맥스바이오 주식회사 화학적 금속염을 포함하지 않는 식물성 연질캡슐조성물

Also Published As

Publication number Publication date
PL3737713T3 (pl) 2022-12-19
KR102354921B1 (ko) 2022-01-21
DK3737713T1 (da) 2020-11-30
EP3737713A1 (en) 2020-11-18
CN111566158A (zh) 2020-08-21
WO2019137717A1 (en) 2019-07-18
CN111566158B (zh) 2021-08-20
AU2018401537B2 (en) 2022-05-19
AU2018401537A1 (en) 2020-08-27
US10711119B2 (en) 2020-07-14
DE18829234T1 (de) 2021-02-18
EP3737713B1 (en) 2022-08-10
US20190211189A1 (en) 2019-07-11
KR20200106073A (ko) 2020-09-10
PT3737713T (pt) 2022-09-13
ES2796329T1 (es) 2020-11-26
ES2796329T3 (es) 2022-11-07
PH12020551041A1 (en) 2021-09-01
JP2021510154A (ja) 2021-04-15
JP7097449B2 (ja) 2022-07-07
HUE059850T2 (hu) 2023-01-28
WO2019137717A4 (en) 2019-09-19

Similar Documents

Publication Publication Date Title
IL273146A (en) Preparations and methods for depositing silicon-containing layers
EP3405577B8 (en) Compositions and methods for inhibiting factor d
IL268684A (en) Preparations and methods for immuno-oncology
PL3589684T3 (pl) Kompozycja polimerowa na folię o dużej zdolności do rozpadania
IL271680A (en) Compositions and methods for inhibiting expression of HMGB1
EP3381448A4 (en) HEMOSTATIC AND WOUND PROTECTION MOUSING FILM
ZA202001320B (en) Compounds and compositions for ire1 inhibition
GB201804548D0 (en) Pharmaceutical compositions
GB201705303D0 (en) Pharmaceutical compositions
DK3737713T3 (en) Carrageenan-Based Compositions for Films and Capsules
EP3773654C0 (en) POLYPHARMACEUTICAL DRUG COMPOSITIONS AND ASSOCIATED METHODS
EP3236993A4 (en) Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
IL284327A (en) Compounds and Methods for Inhibiting Expression of HMGB1
EP3687628A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING ACSS2
GB201807053D0 (en) Pharmaceutical composition
IL279877A (en) Ibusidanib forms and pharmaceutical preparations
IL274524A (en) Preparations and methods for aquaculture
SG11202103374TA (en) Pharmaceutical composition
GB201808571D0 (en) Pharmaceutical compositions
GB201705797D0 (en) Packaging films
ZA202104261B (en) Combination pharmaceutical compositions and methods thereof
EP3856184A4 (en) COMPOSITIONS AND METHODS OF INHIBITING ACSS2
GB201905509D0 (en) Pharmaceutical compositions and associated lits and uses
GB201808567D0 (en) Pharmaceutical compositions
EP3408281A4 (en) METHOD AND COMPOSITIONS FOR DETECTING MYCOPLASMA EXPOSURE